Advisory Commission on Childhood Vaccines, 54391 [2020-19257]

Download as PDF 54391 Federal Register / Vol. 85, No. 170 / Tuesday, September 1, 2020 / Notices positive) with COVID–19, the cumulative number of clients with COVID–19, the number of clients who received services in each RWHAP service category (identified in Policy Clarification Notice 16–02 Ryan White HIV/AIDS Program Services: Eligible Individuals and Allowable Uses of Funds), and the types of services provided using telehealth technology in the COVID–19 Data Report. The information obtained in this module will assist HRSA in understanding how CARES Act RWHAP funding is being used to support RWHAP clients and immediate household members and ensure that HRSA is compliant with federal reporting requirements. Likely Respondents: All RWHAP providers (regardless of whether they are recipients or subrecipients) who receive CARES Act RWHAP funding. Burden Statement: Burden in this context means the time expended by persons to generate, maintain, retain, disclose or provide the information requested. This includes the time needed to review instructions; to develop, acquire, install, and utilize technology and systems for the purpose of collecting, validating, and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information; to search data sources; to complete and review the collection of information; and to transmit or otherwise disclose the information. The total annual burden hours estimated for this ICR are summarized in the table below. TOTAL ESTIMATED ANNUALIZED BURDEN HOURS Form name Number of respondents Number of responses per respondent Total responses Average burden per response (in hours) Total burden hours COVID–19 Data Report ....................................................... 2045 12 24,540 2 49,080 2045 ........................ 24,540 ........................ 49,080 HRSA specifically requests comments on (1) the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, (2) the accuracy of the estimated burden, (3) ways to enhance the quality, utility, and clarity of the information to be collected, and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Maria G. Button, Director, Executive Secretariat. [FR Doc. 2020–19247 Filed 8–31–20; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Advisory Commission on Childhood Vaccines Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice; correction. AGENCY: The original Federal Register Notice announcing the September 2020 Advisory Commission on Childhood Vaccines (ACCV) meeting indicated that this meeting would be held on September 3–4, 2020. This meeting is not being conducted over 2 days, and instead will only take place only on September 4, 2020. The ACCV will hold a public meeting on September 4, 2020, at 10:00 a.m. ET. jbell on DSKJLSW7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 19:00 Aug 31, 2020 Jkt 250001 The meeting will be held via Adobe Connect and telephone conference. This will not be an in-person meeting. The public can join the meeting by: 1. (Audio Portion) Calling the conference phone number 888–790– 1734 and providing the following information: Leader Name: Ms. Tamara Overby Passcode: 4177683 2. (Visual Portion) Connecting to the ACCV Adobe Connect Meeting using the following URL: https://hrsa.connect solutions.com/accv/. Participants should call and connect 15 minutes prior to the meeting in order for logistics to be set up. If you have never attended an Adobe Connect meeting, please test your connection using the following URL: https://hrsa.connectsolutions. com/common/help/en/support/ meeting_test.htm and get a quick overview by following URL: http:// www.adobe.com/go/connectpro_ overview. Information about the ACCV and the agenda for this public meeting can be obtained by accessing the following website: https://www.hrsa.gov/advisorycommittees/vaccines/index.html. FOR FURTHER INFORMATION CONTACT: Annie Herzog, Program Analyst, Division of Injury Compensation Programs (DICP), HRSA, in one of three ways: (1) Send a request to the following address: Annie Herzog, Program Analyst, DICP, HRSA, 5600 Fishers Lane, 08N146B, Rockville, Maryland 20857; (2) call (301) 443–6593; or (3) send an email to ACCV@hrsa.gov. Meeting times could change. For the latest information regarding the PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 meeting, including start time, please check the ACCV website: http:// www.hrsa.gov/advisorycommittees/ childhoodvaccines/index.html. This meeting will only take place on September 4, 2020, and is not being conducted over 2 days (September 3–4, 2020) as stated in a previous Federal Register Notice. Maria G. Button, Director, Executive Secretariat. [FR Doc. 2020–19257 Filed 8–31–20; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Exploring the Roles of Biomolecular E:\FR\FM\01SEN1.SGM 01SEN1

Agencies

[Federal Register Volume 85, Number 170 (Tuesday, September 1, 2020)]
[Notices]
[Page 54391]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-19257]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Commission on Childhood Vaccines

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The original Federal Register Notice announcing the September 
2020 Advisory Commission on Childhood Vaccines (ACCV) meeting indicated 
that this meeting would be held on September 3-4, 2020. This meeting is 
not being conducted over 2 days, and instead will only take place only 
on September 4, 2020.
    The ACCV will hold a public meeting on September 4, 2020, at 10:00 
a.m. ET. The meeting will be held via Adobe Connect and telephone 
conference. This will not be an in-person meeting. The public can join 
the meeting by:
    1. (Audio Portion) Calling the conference phone number 888-790-1734 
and providing the following information:

Leader Name: Ms. Tamara Overby
Passcode: 4177683

    2. (Visual Portion) Connecting to the ACCV Adobe Connect Meeting 
using the following URL: https://hrsa.connectsolutions.com/accv/. 
Participants should call and connect 15 minutes prior to the meeting in 
order for logistics to be set up. If you have never attended an Adobe 
Connect meeting, please test your connection using the following URL: 
https://hrsa.connectsolutions.com/common/help/en/support/meeting_test.htm and get a quick overview by following URL: http://www.adobe.com/go/connectpro_overview.

Information about the ACCV and the agenda for this public meeting can 
be obtained by accessing the following website: https://www.hrsa.gov/advisory-committees/vaccines/index.html.

FOR FURTHER INFORMATION CONTACT: Annie Herzog, Program Analyst, 
Division of Injury Compensation Programs (DICP), HRSA, in one of three 
ways: (1) Send a request to the following address: Annie Herzog, 
Program Analyst, DICP, HRSA, 5600 Fishers Lane, 08N146B, Rockville, 
Maryland 20857; (2) call (301) 443-6593; or (3) send an email to 
[email protected]. Meeting times could change. For the latest information 
regarding the meeting, including start time, please check the ACCV 
website: http://www.hrsa.gov/advisorycommittees/childhoodvaccines/index.html.
    This meeting will only take place on September 4, 2020, and is not 
being conducted over 2 days (September 3-4, 2020) as stated in a 
previous Federal Register Notice.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2020-19257 Filed 8-31-20; 8:45 am]
BILLING CODE 4165-15-P